Literature DB >> 12564389

The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity.

Elizabeth Mazzio1, Karam F A Soliman.   

Abstract

1-Methyl-4-phenylpyridinium (MPP+) is a mitochondrial Complex I inhibitor and is frequently used to investigate the pathological degeneration of neurons associated with Parkinson's disease (PD). In vitro, extracellular concentration of glucose is one of the most critical factors in establishing the vulnerability of neurons to MPP+ toxicity. While glucose is the primary energy fuel for the brain, central nervous system (CNS) neurons can also take up and utilize other metabolic intermediates for energy. In this study, we compared various monosaccharides, disaccharides, nutritive/non-nutritive sugar alcohols, glycolytic and gluconeogenic metabolic intermediates for their cytoprotection against MPP+ in murine brain neuroblastoma cells. Several monosaccharides were effective against MMP+ (500 microM) including glucose, fructose and mannose, which restored cell viability to 109 +/- 5%, 70 +/- 5%, 99 +/- 3% of live controls, respectively. Slight protective effects were observed in the presence of 3-phosphoglyceric acid and glucose-6-phosphate; however, no protective effects were exhibited by galactose, sucrose, sorbitol, mannitol, glycerol or various gluconeogenic and ketogenic amino acids. On the other hand, fructose 1,6 bisphosphate and gluconeogenic energy intermediates [pyruvic acid, malic acid and phospho(enol)pyruvate (PEP)] were neuroprotective against MPP+. The gluconeogenic intermediates elevated intracellular levels of ATP and reduced propidium iodide (PI) nucleic acid staining to live controls, but did not alter the MPP(+)-induced loss of mitochondrial O2 consumption. These data indicate that malic acid, pyruvic acid and PEP contribute to anaerobic substrate level phosphorylation. The use of hydrazine sulfate to impede gluconeogenesis through PEP carboxykinase (PEPCK) inhibition heightened the protective effects of energy substrates possibly due to attenuated ATP demands from pyruvate carboxylase (PC) activity and pyruvate mitochondrial transport. It was concluded from these studies that several metabolic intermediates are effective in fueling anaerobic glycolysis during mitochondrial inhibition by MPP+.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12564389     DOI: 10.1016/s0161-813x(02)00110-9

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  17 in total

1.  The protective role of D-glucose against 1-methyl-4-phenylpyridinium ion (MPP+): induced mitochondrial dysfunction in C6 astroglial cells.

Authors:  Ramesh B Badisa; Selina F Darling-Reed; Karam F A Soliman
Journal:  Neurochem Res       Date:  2010-05-28       Impact factor: 3.996

2.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

3.  MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.

Authors:  Amrita Datta Chaudhuri; Savan Kabaria; Doo Chul Choi; M Maral Mouradian; Eunsung Junn
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

4.  Key role of hydrazine to the interaction between oxaloacetic against phosphoenolpyruvic carboxykinase (PEPCK): ONIOM calculations.

Authors:  Pongthep Prajongtat; Darinee Sae-Tang Phromyothin; Supa Hannongbua
Journal:  J Mol Model       Date:  2013-04-27       Impact factor: 1.810

5.  Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.

Authors:  Lance M Villeneuve; Phillip R Purnell; Michael D Boska; Howard S Fox
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

6.  Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.

Authors:  M Victoria Ruiz-Pérez; Miguel Ángel Medina; José Luis Urdiales; Tuomo A Keinänen; Francisca Sánchez-Jiménez
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

7.  Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines.

Authors:  Elizabeth A Mazzio; Youssef I Soliman; Karam F A Soliman
Journal:  Cell Biol Toxicol       Date:  2010-04-18       Impact factor: 6.691

Review 8.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

9.  Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

Authors:  Christian Carpéné; Josep Mercader; Sophie Le Gonidec; Stéphane Schaak; Jeanne Mialet-Perez; Alexia Zakaroff-Girard; Jean Galitzky
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

Review 10.  Epilepsy, regulation of brain energy metabolism and neurotransmission.

Authors:  Jean-François Cloix; Tobias Hévor
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.